PUT/ABBOTT LABORATORIES/100/0.1/20.09.24 Stock

Warrant

DE000GG0YGH7

Real-time BOERSE MUENCHEN 02:25:33 2024-07-16 pm EDT
0.215 EUR +3.37% Intraday chart for PUT/ABBOTT LABORATORIES/100/0.1/20.09.24
Current month+8.90%
1 month-14.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.215 +3.37%
24-07-15 0.208 +5.05%
24-07-12 0.198 -9.17%
24-07-11 0.218 -21.86%
24-07-10 0.279 -12.81%

Real-time BOERSE MUENCHEN

Last update July 16, 2024 at 02:25 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GG0YGH
ISINDE000GG0YGH7
Date issued 2023-12-11
Strike 100 $
Maturity 2024-09-20 (66 Days)
Parity 10 : 1
Emission price 0.46
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.422
Lowest since issue 0.115
Spread 0.02
Spread %8.33%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
103 USD
Average target price
124.8 USD
Spread / Average Target
+21.20%
Consensus